Boehringer Ingelheim announces 2020 ‘BVDzero Case Awards’

Boehringer Ingelheim aims to encourage the search for both clinical and subclinical cases of BVD (Bovine viral diarrhea) in cattle herds. ( Boehringer Ingelheim )

Boehringer Ingelheim is announcing the 2020 ‘BVDzero Case Awards’, now open for applications. The bi-annual awards reflect Boehringer Ingelheim’s long-term commitment to promoting the health and well-being of farm animals.

 The company will provide a total prize of 15,000 euros for the top 10 clinical cases entered. Any person involved in the cattle industry is eligible for participation. Areas of expertise include, but are not limited to, research, diagnostics, animal science, veterinary practice, production veterinary medicine, cattle production and animal health & welfare. The list of the 2018 winners which also includes the awarded amounts is available here.

Through the ‘BVDzero Case Awards’, Boehringer Ingelheim aims to encourage the search for both clinical and subclinical cases of BVD (Bovine viral diarrhea) in cattle herds. The company believes that it will help increase the awareness of BVD and, as a result, help reduce its prevalence. Applications can be submitted until 20 March 2020.

 “Bovine viral diarrhea is one of the most common diseases in cattle, causing harm to the affected animals and huge economic damage to the livestock industry. We aim to challenge the status quo and bring a paradigm shift in the control of BVD globally,” explained Steve Williams, Head of Global Ruminants/Cattle Strategic Business Unit at Boehringer Ingelheim.

The award ceremony will take place at this year’s BVDzero Press Conference held in May 2020. The winners will be selected by the BVDzero Committee, consisting of renowned external experts in the field of bovine health.

More information is available on BVDzero website.

For more on BVD and control strategies, see these articles from BovineVetOnline:

Addressing BVD at the source

BVD: Biosecurity, vaccination and diagnostics

Bovine Viral Dilemma

Comments